Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Xtant Medical (XTNT) Prnewswire·2025-04-16 20:05Xtant Medical (XTNT) Prnewswire·2025-04-16 20:05
R1Xtant Medical (XTNT) Prnewswire·2025-04-16 20:05